COVID-19's effects on symptoms associated with benign prostatic hyperplasia.
| Autor: | Sofronievska Glavinov, Maja, Petrovska, Tanja, Chabukovska Radulovska, Jasminka, Tahir, Shenol, Arsov, Stefan |
|---|---|
| Předmět: |
URINARY tract infections
RISK assessment T-test (Statistics) DATA analysis QUALITATIVE research HOSPITAL care MULTIPLE regression analysis DESCRIPTIVE statistics CHI-squared test URINARY catheterization SEVERITY of illness index BENIGN prostatic hyperplasia STATISTICS DATA analysis software COVID-19 COMORBIDITY DISEASE risk factors |
| Zdroj: | Discover Public Health; 9/16/2024, Vol. 21 Issue 1, p1-9, 9p |
| Abstrakt: | Purpose: The objective of this study was to identify the relationship between COVID-19 and lower urinary tract symptoms in patients with benign prostatic hyperplasia. Materials and methods: Data from forty outpatients who had recovered from COVID-19 and had previously been diagnosed with and treated medically for benign prostatic hyperplasia were assessed. Pre- and post-COVID-19 assessments were also conducted for prostate volume, total serum PSA concentration, and lower urinary tract symptoms. Hospitalizations related to COVID-19, the time interval between COVID-19 recovery and urologist referrals, and comorbidities were considered. Independent Student's t-tests or chi-square tests were used to compare changes in all variables. For the Spearman rank correlation analysis, only variables with a univariate analysis of p < 0.10 were included in the multiple regression models, with the significance threshold set at two-tailed p < 0.05. Results: After COVID-19, there was an increase in IPSS (12.87 ± 3.76), total serum PSA (1.56 ± 0.87), and prostate volume (10.68 ± 11.73). Multiple linear regression analysis of the independent predictors of IPSS increase revealed pre-COVID-19 IPSS with intermittency and straining as leading symptoms and bladder catheterization during COVID-19. Pre-COVID-19 frequency and nocturia status were found to be independent predictors of increased blood volume, hospital treatment for COVID-19, and bladder catheterization. A weak stream, UTI, and hypertension were found to be independent predictors of a PSA increase. The time from COVID-19 recovery to urologist referral was shorter in patients with post-COVID-19 IPSS increase (p < 0.05). Conclusion: Determining the predictors of the effects of COVID-19 on worsening BPH symptoms is essential for continued monitoring and treatment. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |